Patents by Inventor Maria Jose Martinez Velon

Maria Jose Martinez Velon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Particle size stabilization process
    Patent number: 10888500
    Abstract: The present invention provides a new process for stabilizing the particle size of micronized glycopyrronium salt (such as glycopyrronium bromide) which yields a micronized product exhibiting improved chemical and polymorphic stability even after prolonged storage. The invention also relates to compositions comprising said stabilized glycopyrronium salt (such as glycopyrronium bromide) and to dry powder inhaler devices and capsules or blisters comprising the stabilized glycopyrronium salt (such as glycopyrronium bromide). The glycopyrronium salt (such as glycopyrronium bromide) or compositions of the invention may be used as a medicament, for instance in the treatment of asthma, chronic obstructive pulmonary disease or cystic fibrosis or related diseases.
    Type: Grant
    Filed: July 25, 2017
    Date of Patent: January 12, 2021
    Assignee: INKE, S.A.
    Inventors: Josep Terradas Camins, Josep Maria Carulla Oliver, Silvia Donnici Garcia, David Gomez Lamarca, Maria Jose Martinez Velon, Emma Recio Soler
  • PARTICLE SIZE STABILIZATION PROCESS
    Publication number: 20190175451
    Abstract: The present invention provides a new process for stabilizing the particle size of micronized glycopyrronium salt (such as glycopyrronium bromide) which yields a micronized product exhibiting improved chemical and polymorphic stability even after prolonged storage. The invention also relates to compositions comprising said stabilized glycopyrronium salt (such as glycopyrronium bromide) and to dry powder inhaler devices and capsules or blisters comprising the stabilized glycopyrronium salt (such as glycopyrronium bromide). The glycopyrronium salt (such as glycopyrronium bromide) or compositions of the invention may be used as a medicament, for instance in the treatment of asthma, chronic obstructive pulmonary disease or cystic fibrosis or related diseases.
    Type: Application
    Filed: July 25, 2017
    Publication date: June 13, 2019
    Inventors: Josep Terradas Camins, Josep Maria Carulla Oliver, Silvia Donnici Garcia, David Gomez Lamarca, Maria Jose Martinez Velon, Emma Recio Soler